A pharmaceutical revolution

A pharmaceutical revolution

The increase in the cost of therapies has given rise to the need for Health Technology Assessment (HTA) agencies in the developed world. The UK's National Institute for Health and Clinical Excellence (NICE) leads the field and primarily uses the Quality Adjusted Life Year (QALY) afforded by a t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical technology Europe 2010-12, Vol.22 (12), p.29
Hauptverfasser: Berman, Gregory, Damms, Bob, Rhodes, Ian
Format: Artikel
Sprache:eng
Schlagworte:
Business models
Cancer therapies
Communication
Compliance
Cost control
Diabetes
Glucose
Health technology assessment
Industry forecasts
Integrated approach
Medical equipment
Medical technology
Patients
Pharmaceutical industry
Pharmaceuticals
Prescription drugs
Product development
Production management
Reimbursement
Suppliers
Technology adoption
Technology application
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The increase in the cost of therapies has given rise to the need for Health Technology Assessment (HTA) agencies in the developed world. The UK's National Institute for Health and Clinical Excellence (NICE) leads the field and primarily uses the Quality Adjusted Life Year (QALY) afforded by a treatment to decide whether it should be reimbursed. This evaluation is usually (although not exclusively) made at the patient population level.
ISSN:1753-7967